Article
18 June 2025 - by Kristin Niakan, Hiram Satterwhite, Briana Botros
Progyny patients undergoing assisted reproductive technology experience better clinical fertility outcomes across six national benchmarks.
Article
17 December 2024 - by Melanie K. Kuester, Kristin Niakan, Brittany Schock
From manufacturer rebates to risk corridors, Milliman pharmacy experts discuss strategies for paying for high-cost drugs.
Article
12 November 2024 - by Briana Botros, Kristin Niakan, Brittany Schock
Amid the development of new cell and gene therapies, we present some strategies that states have used to control costs and risk among their MCOs.
Video
30 October 2024 - by Mark F. Gruenhaupt, RPh, Matthew Hayes, Kristin Niakan
Hear how pharmacy benefit manager profits are shifting amid new rebate credits, legislative trends, and PBMs’ expansion into biosimilars distribution.
Article
10 June 2024 - by Jake K. Klaisner, AJ Ally, Briana Botros, Kristin Niakan, Ryan LeRoy
We examine the impact of anti-obesity medication coverage in the Medicaid and commercial markets, as drugs such as Wegovy and Zepbound take off.
Article
29 April 2024 - by Julia Shelton, Kristin Niakan, Katie McBride
Key strategies for self-funded employers on managing specialty drug costs through Alternative Funding Programs (AFPs), focusing on projected vs. realized savings, compliance, and member impact and eligibility considerations.
Article
18 January 2024 - by Kristin Niakan, Brittany Schock
We explore the recent growth in utilization and spending in Medicaid for glucagon-like peptide-1 agonists, used for type 2 diabetes and chronic weight management.
Article
18 January 2024 - by Ellyn Russo, Michelle (Klein) Robb, Kristin Niakan
With CMS amplifying its commitment to health equity, we discuss some recent agency initiatives and provide actions for Medicare Advantage organizations to take.
Article
08 December 2023 - by Kristin Niakan, Ellyn Russo, Michelle (Klein) Robb
We delve into three recent CMS health-equity-focused initiatives, which have significant implications for Medicare Advantage organizations.
Article
29 November 2023 - by Kristin Niakan, Ketaki Nagarkar, Ellyn Russo
In our analysis of screenings by insurance type for four major cancers, Medicare Advantage had higher utilization, while managed Medicaid had the lowest.